Insider trade

CEO sold ~$113K of BSX shares in the open market

Traded Feb 2, 2026 · Filed Feb 3, 2026

Boston ScientificBSX

~$113K
Reported value · 1,200 sh @ $94.0567: 1.57M
Holds after · shares reported: -52.9%
stock since the trade · S&P 500 +9.9%, $91.87 → $43.23 on Oct 1

Why it stands out

The boss of Boston Scientific sold $113K of Boston Scientific shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 2, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 3, 2026

CEO$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$112,868

Shares × reported transaction price

Timing vs results

103 days after results of Oct 22, 2025, 2 days before results of Feb 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $91.87 on Feb 2, 2026, within 5% of its 52-week low, after a 3% drop over the previous 30 trading days

52-week range $88.07 (Jan 16, 2026) to $108.14 (Sep 8, 2025), 19% of the way up, from 251 adjusted closes. 30 trading days earlier: $94.48 on Dec 17, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-2.7%	+0.8%	-3.5%
30 days	-5.5%	-2.0%	-3.5%
90 days	-25.9%	+5.5%	-31.3%
180 days	-35.9%	+10.4%	-46.3%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-26-001156
Filed / recorded: Feb 3, 2026, 9:12 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BOSTON SCIENTIFIC CORP
Issuer CIK: 885725
Ticker: BSX
Reporting person: Michael F Mahoney
Relationship: Director, Officer
Officer title: Chairman, President & CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 2, 2026
Transaction code: S
Shares / units: 1,200
Price per share: $94.0567
Acquired / disposed: Disposed (D)
Shares owned after: 1,571,436
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Around the same time

7mo ago

24Derivative units

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

24Shares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

7mo ago

556Shares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record